P7M
N-[(5-bromothiophen-2-yl)sulfonyl]-2,4-dichlorobenzamide
Find entries where: P7M
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
|---|---|
| Name | N-[(5-bromothiophen-2-yl)sulfonyl]-2,4-dichlorobenzamide |
| Synonyms | Tasisulam |
| Identifiers | ~{N}-(5-bromanylthiophen-2-yl)sulfonyl-2,4-bis(chloranyl)benzamide |
| Formula | C11 H6 Br Cl2 N O3 S2 |
| Molecular Weight | 415.11 |
| Type | NON-POLYMER |
| Isomeric SMILES | c1cc(c(cc1Cl)Cl)C(=O)NS(=O)(=O)c2ccc(s2)Br |
| InChI | InChI=1S/C11H6BrCl2NO3S2/c12-9-3-4-10(19-9)20(17,18)15-11(16)7-2-1-6(13)5-8(7)14/h1-5H,(H,15,16) |
| InChIKey | WWONFUQGBVOKOF-UHFFFAOYSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 26 |
| Chiral Atom Count | 0 |
| Bond Count | 27 |
| Aromatic Bond Count | 11 |
Drug Info: DrugBank
| DrugBank ID | DB11941 |
|---|---|
| Name | Tasisulam |
| Groups | investigational |
| Description | Tasisulam has been used in trials studying the treatment and basic science of Melanoma, Lymphoma, Solid Tumors, Breast Cancer, and Ovarian Cancer, among others. |
| Synonyms |
|
| Categories |
|
| CAS number | 519055-62-0 |
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 10160238 |
| ChEMBL | CHEMBL2110587 |
